Suppr超能文献

早期乳腺癌术中电子放疗真实世界数据的结果:单中心长期复发和生存结果

Outcomes From Real-World Data on Intraoperative Electronic Radiotherapy for the Treatment of Early-Stage Breast Cancer: Long-Term Recurrence and Survival Outcomes From a Single Center.

作者信息

De la Mata Dolores, Santiago-Concha Bernardino Gabriel, Bargalló-Rocha Juan Enrique, Robles-Vidal Carlos Daniel, Gómez-Pue Daniella, Castorena-Rojí Gerardo, Hinojosa-Gómez José, Flores-Vázquez Fabiola, Blake-Cerda Mónika, Enriquez-Barrera Mario, Maffuz-Aziz Antonio

机构信息

Department of Radiation Oncology, Centro Médico ABC, Mexico City, Mexico.

Department of Oncology Surgery/Gynecology Surgery, Centro Médico ABC, Mexico City, Mexico.

出版信息

Int J Breast Cancer. 2024 Nov 14;2024:6207762. doi: 10.1155/2024/6207762. eCollection 2024.

Abstract

This study is aimed at investigating the 10-year outcomes of intraoperative radiotherapy (IORT) in Mexican women with early breast cancer (EBC) treated at the Centro Medico ABC, Mexico City. A cohort study included women with early-stage invasive ductal carcinoma aged ≥ 45 years without prior oncologic treatment, tumor size ≤ 3.5 cm, cN0M0, positive hormone receptors, margins ≥ 2 mm, negative sentinel lymph nodes, and no extensive lymphovascular invasion. IORT was administered at 20 Gy for 20-30 min after a lumpectomy. Follow-up extended over 10 years and included clinical examinations every 6 months for the first 18 months, followed by annual mammograms and conventional examinations. Patients out of the criteria were excluded from this study because they were referred for additional surgery and/or whole-breast radiation therapy. The study involved 238 patients with an average age of 61.1 years. The mean tumor size was 12 mm, and the percentages of lymphatic invasion, positive hormone receptors, and HER2/neu overexpression were 12.6%, 90.8%, and 2.1%, respectively. The median follow-up was 66.6 months (range: 1-126 months), and the overall survival and mastectomy-free rate reached 95.7% and 90%, respectively. Thirteen patients showed side effects; four recurrences were recorded, of which 50% were out-field relapses. The 5-year Kaplan-Meier probability of local relapses, mastectomy-free, and overall survival reached 97.5%, 100%, and 98%, respectively. This is the first 10-year report about the effect of IORT on Mexican women with EBC in the early stages. Strict adherence to the selection criteria in this study resulted in low rates of side effects, mortality, and local recurrences, demonstrating that IORT is an effective treatment alternative for patients with EBC. Studies with a longer follow-up period should be performed, as recurrences can occur in the long term.

摘要

本研究旨在调查在墨西哥城ABC医疗中心接受治疗的患有早期乳腺癌(EBC)的墨西哥女性术中放疗(IORT)的10年疗效。一项队列研究纳入了年龄≥45岁、未曾接受过肿瘤治疗、肿瘤大小≤3.5 cm、cN0M0、激素受体阳性、切缘≥2 mm、前哨淋巴结阴性且无广泛淋巴管浸润的早期浸润性导管癌女性。在肿块切除术后,给予20 Gy的IORT,持续20 - 30分钟。随访时间超过10年,包括在最初18个月内每6个月进行一次临床检查,随后每年进行乳房X光检查和常规检查。不符合标准的患者被排除在本研究之外,因为他们被转诊进行额外的手术和/或全乳放疗。该研究涉及238名患者,平均年龄为61.1岁。平均肿瘤大小为12 mm,淋巴管浸润、激素受体阳性和HER2/neu过表达的百分比分别为12.6%、90.8%和2.1%。中位随访时间为66.6个月(范围:1 - 126个月),总生存率和保乳率分别达到95.7%和90%。13名患者出现了副作用;记录到4例复发,其中50%为野外复发。5年Kaplan - Meier局部复发、保乳和总生存概率分别达到97.5%、100%和98%。这是关于IORT对早期EBC墨西哥女性疗效的首份10年报告。本研究严格遵守选择标准,导致副作用、死亡率和局部复发率较低,表明IORT是EBC患者的一种有效治疗选择。由于长期可能会出现复发,应进行随访期更长的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa5/11581795/63f8c0f24262/IJBC2024-6207762.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验